Drug Profile
Research programme: tocopheryl succinate nano-emulsion formulation - ADVENTRX Pharmaceuticals
Alternative Names: Alpha-tocopheryl succinate - ADVENTRX Pharmaceuticals; ANX-575; SDP-112; α-tocopheryl succinate - ADVENTRX PharmaceuticalsLatest Information Update: 30 Oct 2008
Price :
$50
*
At a glance
- Originator ADVENTRX Pharmaceuticals
- Class Antineoplastics; Tocopherols; Vitamins
- Mechanism of Action Antioxidants; Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 30 Jan 2007 ANX 575 is available for licensing (http://www.adventrx.com)
- 28 Apr 2006 SD Pharmaceuticals has been acquired by ADVENTRX Pharmaceuticals
- 12 Apr 2006 Preclinical trials in Cancer in USA (unspecified route)